Expert Interview
Digesting the recent data from Sarepta's SRP-9001-102 study in treating Duchenne Muscular Dystrophy
Ticker(s): SRPTInstitution: Children's Hospital of Richmond (at VCU)
- Assistant Professor, Division of Child Neurology at VCU & Dual-board certified child neurologist and neuromuscular physician.
- Currently treats 60 to 70 patients with DMD.
- Clinical and research interests are in pediatric neuromuscular disorders with a particular focus on Duchenne Muscular Dystrophy; has served as the PI of several clinical trials in DMD and site investigator for Exon 51.
Roughly how many patients with DMD do you currently manage?
Added By: c_adminWhat were your thoughts on the data released by Sarepta on Jan 10th?
Added By: c_adminOn a scale from 1-10 (10 being extremely excited) where would you rate your level of excitement for this therapy?
Added By: c_admindo you think micro dystrophin works
Added By: useree15bbfaAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
